Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Documents on Display - Share Scheme - 2025 SHARE AWARD SCHEME
2025-01-15
Documents on Display - Share Scheme - 2025 SHARE OPTION SCHEME
2025-01-15
Form of Proxy for the Extraordinary General Meeting to be held on Monday, February 3, 2025
2025-01-15
Notice of Extraordinary General Meeting
2025-01-15
Circulars - (1) Proposed Adoption of The 2025 Share Option Scheme and The 2025 Share Award Scheme; and (2) Conditional Grants of Options Under The 2025 Share Option Scheme and Share Awards Under The 2025 Share Award Scheme; and (3) Notice of Extraordinary
2025-01-15
(1) Proposed Adoption of the 2025 Share Option Scheme and the 2025 Share Award Scheme; and (2) Conditional Grants of Options under the 2025 Share Option Scheme and Share Awards under the 2025 Share Award Scheme
2025-01-14
Book Closure Period for the Extraordinary General Meeting
2025-01-14
Next Day Disclosure Returns - Share Buyback
2025-01-09
Next Day Disclosure Returns - Share Buyback
2025-01-07
Next Day Disclosure Returns - Share Buyback
2025-01-06

1

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1